In particular, they observed that dyslipidemia in mice fed a HFD up-regulates GSK3α activity, which increases PPARα phosphorylation at serine 280 (Ser280), thereby increasing gene transcription of CD36/FAT and fatty acid transport protein 1, but not PPARα-regulated genes involved in enhancing fatty acid oxidation. Here, CD36 is linked to metabolic syndrome.